CCA
BSX icon

Childress Capital Advisors’s Boston Scientific BSX Stock Holding History

Childress Capital Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,802
Closed -$239K – 386
2026
Q1 		$239K Sell
3,802
-2,890
-43% -$231K 0.04% 322
2025
Q4 		$638K Buy
6,692
+93
+1% +$9.12K 0.1% 147
2025
Q3 		$644K Buy
6,599
+272
+4% +$28.2K 0.12% 128
2025
Q2 		$680K Buy
6,327
+264
+4% +$26.7K 0.17% 91
2025
Q1 		$612K Sell
6,063
-138
-2% -$13.9K 0.18% 83
2024
Q4 		$554K Buy
6,201
+350
+6% +$30.8K 0.15% 89
2024
Q3 		$490K Buy
5,851
+106
+2% +$8.36K 0.13% 114
2024
Q2 		$442K Sell
5,745
-164
-3% -$12K 0.12% 114
2024
Q1 		$405K Sell
5,909
-764
-11% -$49.1K 0.12% 112
2023
Q4 		$386K Buy
6,673
+169
+3% +$9.02K 0.12% 111
2023
Q3 		$343K Buy
+6,504
New +$341K 0.11% 108
2023
Q1 		– Sell
-6,201
Closed -$287K – 101
2022
Q4 		$287K Buy
6,201
+212
+4% +$9.18K 0.1% 136
2022
Q3 		$236K Buy
5,989
+615
+11% +$24.7K 0.09% 143
2022
Q2 		$200K Buy
5,374
+71
+1% +$2.89K 0.08% 162
2022
Q1 		$234K Buy
+5,303
New +$230K 0.08% 164
2021
Q1 		– Sell
-1,358
Closed -$49K – 272
2020
Q4 		$49K Buy
+1,358
New +$48.9K 0.03% 225

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Childress Capital Advisors's BSX Position: Q2 2026 in Review

Childress Capital Advisors sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,802 shares — an estimated $239K sold.

Childress Capital Advisors first reported a position in BSX in Q4 2020 and held it in 16 quarters. The position peaked at $680K in Q2 2025. 1,478 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Childress Capital Advisors reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Childress Capital Advisors sold 3,802 Boston Scientific shares in Q2 2026, an estimated $239K.
  • Childress Capital Advisors first reported a position in Boston Scientific in Q4 2020 and held it in 16 quarters.
  • Childress Capital Advisors's Boston Scientific position peaked at $680K in Q2 2025.
  • 1,478 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Childress Capital Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.